InvestorsHub Logo
Followers 25
Posts 1540
Boards Moderated 0
Alias Born 01/07/2014

Re: None

Wednesday, 11/11/2015 11:05:15 AM

Wednesday, November 11, 2015 11:05:15 AM

Post# of 18730
Per Zacks: Finjans 10q alludes to new license deals

After Finjan’s (NASDAQ:FNJN) win against Blue Coat, we had hoped that licensing deals would accelerate, but Q3 has come and gone without a new one. Additionally, Finjan v. Palo Alto Networks (PANW) has been reassigned and all pending dates will be reset in accordance with the new judges calendar. In Finjan v. Symantec (SYMC), the judge has stayed the case pending a decision by the US Patent and Trademark Office (USPTO) on whether to institute Inter Partes Review (IPR) of Finjan's patent claims in five of eight patents asserted against Symantec. Depending on the PTAB's decision on whether or not to institute those IPRs, the judge will determine whether to extend the stay. This pushes out the calendar on the largest possible win due to the size of Symantec’s revenues in cybersecurity.

However the 10Q, by maintaining the company has enough cash to fund operations for the next 12 months, hints that new deals will soon be reached given its plans and current cash burn do not support that time period.